COMPANY:

INEX Innovate

"INEX Innovate...is pleased to announce the launch of epiHERA® the company’s early endometrial cancer detection technology. epiHERA® was unveiled at the esteemed 2023 Singapore International Congress of Obstetrics and Gynaecology (SICOG), held from August 25th to 27th."

"Inex Innovate of Singapore plans to launch a PCR-based endometrial cancer detection test this summer, following interim results from a clinical study with researchers at the Chinese University of Hong Kong that were presented here at the Association of Molecular Pathology 2023 Europe Congress this week."

"INEX INNOVATE...announces...that it has entered an agreement with UK listed Yourgene PLC (LON: YGEN) to acquire 100% of its Taiwan genomics business Yourgene Health (Taiwan) Co,. Ltd. A genomics company with sales in Hong Kong, Japan and Taiwan...This strategic move marks a significant milestone in INEX's journey of growth and expansion in the field of reproductive, fetal and women's oncology diagnostics and importantly expands our footprint from South East Asia into the markets of North Asia."

"INEX Innovate is delighted to announce the appointment of Biomed Global as distributor for the launch of OvaCis® - The Company’s Test for Ovarian Cancer in Indonesia, Malaysia, Philippines, Singapore and Thailand."

"Inex Innovate...announced on Wednesday that its ovarian cancer test has received CE marking...The point-of-care OvaCis Rapid Test determines whether an ovarian cyst is benign or malignant by measuring haptoglobin, a protein biomarker that is evenly distributed in ovarian cyst fluid. It requires minimal training and five minutes of hands-on time and returns results in 15 minutes."